Innate Pharma has named Dr. Mondher Mahjoubi as the chairman of the executive board. The new chairman of the executive board is to succeed co-founder, Dr. Herve Brailly, who transitions to chairman of the supervisory board. Dr. Mahjoubi brings more than 20 years of clinical development, marketing and strategy experience to the position, most recently from AstraZeneca where he was senior vice president and therapeutic area head for oncology, global product and portfolio strategy.